Javascript must be enabled to continue!
The second ‘gallbladder operation’
View through CrossRef
Background:
Subtotal cholecystectomy has been reported in 8% and 3.3% of patients undergoing open and laparoscopic cholecystectomy, respectively. According to a recent nationwide survey, the utilisation of subtotal cholecystectomy in the treatment of acute cholecystitis is on the rise. In 1.8% of subtotal cholecystectomies, a reoperation is required. Reoperations for residual gallbladder (GB), gallstones, and related complications accounted for half of the reoperations described in the literature after subtotal cholecystectomy. The purpose of this study was to evaluate the clinical profile, risk of complications, and feasibility of laparoscopic approaches and surgical procedures in patients with recurrent symptoms from a residual GB that necessitated a completion cholecystectomy.
Methods:
Patients who underwent surgery for residual GB with stones and/or complications between January 2007 and January 2020 were included in the study group. A prospectively maintained database was used to review patient information retrospectively. The demographic profile, operation details of the index surgery, current presentation, investigations performed, surgery details, morbidity and mortality were all included in the clinical information.
Results:
There were 13 patients who underwent completion cholecystectomy. The median age was 55 years (22–63 years). Prior operative notes mentioned subtotal cholecystectomy in only seven patients. The average time between the index surgery and the onset of symptoms was 30 months (2–175 months). A final diagnosis of residual GB with or without calculi was made by ultrasound (USG) in 11 patients and by magnetic resonance cholangiopancreatography (MRCP) in two others. Choledocholithiasis (
n
= 4, 30.7%), acute cholecystitis (
n
= 2, one with empyema and GB perforation) and Mirizzi syndrome (
n
= 1) were seen as complications of residual gallstones in seven patients. All 13 patients underwent successful laparoscopic procedures. A fifth port was used in all. A critical view of safety was achieved in 12 patients. Two patients required laparoscopic common bile duct (CBD) exploration for CBD stones. Intraoperative cholangiograms were done in eight patients (61.5%). There were no conversions, injuries to the bile duct or deaths. Morbidity was seen in one. The patient required therapeutic endoscopic retrograde cholangiography for cholangitis and CBD clearance on the fifth post-operative day. The median hospital stay was 4 days (3–7 days). At a median follow-up of 99 months, symptom resolution was seen in all 13 patients.
Conclusion:
Gallstones in the residual GB are associated with more complications than conventional gallstones. The diagnosis requires a high level of suspicion. MRCP is more accurate in establishing the diagnosis and identifying the associated complications, even if the diagnosis is made on USG in most patients. A pre-operative roadmap is provided by the MRCP. For patients with residual GB, laparoscopic completion cholecystectomy is a feasible and safe option.
Ovid Technologies (Wolters Kluwer Health)
Title: The second ‘gallbladder operation’
Description:
Background:
Subtotal cholecystectomy has been reported in 8% and 3.
3% of patients undergoing open and laparoscopic cholecystectomy, respectively.
According to a recent nationwide survey, the utilisation of subtotal cholecystectomy in the treatment of acute cholecystitis is on the rise.
In 1.
8% of subtotal cholecystectomies, a reoperation is required.
Reoperations for residual gallbladder (GB), gallstones, and related complications accounted for half of the reoperations described in the literature after subtotal cholecystectomy.
The purpose of this study was to evaluate the clinical profile, risk of complications, and feasibility of laparoscopic approaches and surgical procedures in patients with recurrent symptoms from a residual GB that necessitated a completion cholecystectomy.
Methods:
Patients who underwent surgery for residual GB with stones and/or complications between January 2007 and January 2020 were included in the study group.
A prospectively maintained database was used to review patient information retrospectively.
The demographic profile, operation details of the index surgery, current presentation, investigations performed, surgery details, morbidity and mortality were all included in the clinical information.
Results:
There were 13 patients who underwent completion cholecystectomy.
The median age was 55 years (22–63 years).
Prior operative notes mentioned subtotal cholecystectomy in only seven patients.
The average time between the index surgery and the onset of symptoms was 30 months (2–175 months).
A final diagnosis of residual GB with or without calculi was made by ultrasound (USG) in 11 patients and by magnetic resonance cholangiopancreatography (MRCP) in two others.
Choledocholithiasis (
n
= 4, 30.
7%), acute cholecystitis (
n
= 2, one with empyema and GB perforation) and Mirizzi syndrome (
n
= 1) were seen as complications of residual gallstones in seven patients.
All 13 patients underwent successful laparoscopic procedures.
A fifth port was used in all.
A critical view of safety was achieved in 12 patients.
Two patients required laparoscopic common bile duct (CBD) exploration for CBD stones.
Intraoperative cholangiograms were done in eight patients (61.
5%).
There were no conversions, injuries to the bile duct or deaths.
Morbidity was seen in one.
The patient required therapeutic endoscopic retrograde cholangiography for cholangitis and CBD clearance on the fifth post-operative day.
The median hospital stay was 4 days (3–7 days).
At a median follow-up of 99 months, symptom resolution was seen in all 13 patients.
Conclusion:
Gallstones in the residual GB are associated with more complications than conventional gallstones.
The diagnosis requires a high level of suspicion.
MRCP is more accurate in establishing the diagnosis and identifying the associated complications, even if the diagnosis is made on USG in most patients.
A pre-operative roadmap is provided by the MRCP.
For patients with residual GB, laparoscopic completion cholecystectomy is a feasible and safe option.
Related Results
Relationship between gallstones and interstitial cells of Cajal in the gallbladder
Relationship between gallstones and interstitial cells of Cajal in the gallbladder
Introduction:
A high percentage of patients with gallstones exhibit abnormalities in gallbladder emptying, and gallstones are often associated with gallbladder contract...
Preoperative diagnosis of gallbladder volvulus: Clinical case report and review of the literature
Preoperative diagnosis of gallbladder volvulus: Clinical case report and review of the literature
Introduction: Gallbladder volvulus is an uncommon disorder that impedes the circulation of fluid in the gallbladder and blood vessels. Gallbladder volvulus accounts for only 1 in 3...
hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population
hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population
AbstractThe human oxoguanine glycosylase 1(hOGG1) gene encodes a DNA glycosylase that is involved in excision repair of 8‐OH‐dG (8‐hydroxy‐2‐deoxyguanine) from oxidatively‐damaged ...
Gallbladder Position Anomalies: Clinical Impacts and Management
Gallbladder Position Anomalies: Clinical Impacts and Management
Gallbladder position anomalies are rare. Normally, the gallbladder is located at the inferior surface of the right lobe of the liver between segments IV and V, covered by the perit...
Aspartate beta-hydroxylase is a prognostic factor in gallbladder cancer with the function of promoting tumorigenesis and chemoresistance
Aspartate beta-hydroxylase is a prognostic factor in gallbladder cancer with the function of promoting tumorigenesis and chemoresistance
AimsGallbladder cancer is characterized by a dismal prognosis, with a limited number of biological markers currently identified for the carcinogenesis, progression and prognosis of...
MBD1 promotes the malignant behavior of gallbladder cancer cells and induces chemotherapeutic resistance to gemcitabine
MBD1 promotes the malignant behavior of gallbladder cancer cells and induces chemotherapeutic resistance to gemcitabine
AbstractBackgroundMethyl-CpG binding domain protein 1 (MBD1), which couples DNA methylation to transcriptional repression, has been implicated in transcriptional regulation, hetero...
Histopathological variants of gallbladder after cholecystectomy in Eastern Libya: A report of 3412 specimens
Histopathological variants of gallbladder after cholecystectomy in Eastern Libya: A report of 3412 specimens
Background: Cholecystectomy is one of the most common surgical operations and is performed routinely for a variant of gallbladder diseases, including chronic and acute cholecystiti...
Gallbladder agenesis: A rare anomaly of the biliary system
Gallbladder agenesis: A rare anomaly of the biliary system
Dear Editor; A 44-year-old man visited our outpatient clinic for a routine checkup with no complaint. He was not using any medications or alcohol. His vital signs and physical exam...

